Zoledronic acid ‘patient card’ would reduce risk of bone tissue deathUse of a patient reminder card has been recommended by a committee of the European Medicines Agency to minimise the risk of jaw osteonecrosis associated with zoledronic acid.…
Osteoporosis: a disease of the modern world?A lack of vigorous exercise has caused human bones to become weaker over thousands of years.…
Lipophilic bisphosphonates used to target lung cancer A new generation of lipophilic bisphosphonates has been designed to target cancer, with a zoledronic acid analogue demonstrating efficacy against lung adenocarcinoma.…
Latest trials do not support link between bisphosphonate use and reduced breast cancer risk Randomised controlled trials fail to confirm association between osteoporosis treatments and decreased breast cancer risk in postmenopausal women.…
Building bones with nutraceuticals David Appleton and Brian Lockwood discuss bone, osteoporosis and nutraceuticals that can help treat and slow the process of bone depletion.…
